Correlation Between Visa and Aarti Drugs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Visa and Aarti Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Aarti Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and Aarti Drugs Limited, you can compare the effects of market volatilities on Visa and Aarti Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Aarti Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Aarti Drugs.

Diversification Opportunities for Visa and Aarti Drugs

-0.79
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Visa and Aarti is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Aarti Drugs Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aarti Drugs Limited and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Aarti Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aarti Drugs Limited has no effect on the direction of Visa i.e., Visa and Aarti Drugs go up and down completely randomly.

Pair Corralation between Visa and Aarti Drugs

Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.28 times more return on investment than Aarti Drugs. However, Visa Class A is 3.57 times less risky than Aarti Drugs. It trades about 0.26 of its potential returns per unit of risk. Aarti Drugs Limited is currently generating about -0.07 per unit of risk. If you would invest  33,398  in Visa Class A on November 27, 2024 and sell it today you would earn a total of  1,455  from holding Visa Class A or generate 4.36% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy95.24%
ValuesDaily Returns

Visa Class A  vs.  Aarti Drugs Limited

 Performance 
       Timeline  
Visa Class A 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Visa may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Aarti Drugs Limited 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Aarti Drugs Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in March 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Visa and Aarti Drugs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Visa and Aarti Drugs

The main advantage of trading using opposite Visa and Aarti Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Aarti Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aarti Drugs will offset losses from the drop in Aarti Drugs' long position.
Visa vs. American Express
Visa vs. PayPal Holdings
Visa vs. Capital One Financial
Visa vs. Upstart Holdings
The idea behind Visa Class A and Aarti Drugs Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Aarti Drugs vs. Coffee Day Enterprises
Aarti Drugs vs. Sonata Software Limited
Aarti Drugs vs. Speciality Restaurants Limited
Aarti Drugs vs. Transport of
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated


 
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY